2008•Medical Journal of the Chinese People's Armed Police ForcesRequires access

Effects of mifepristone on expressions of ER,PR,bcl-2 and bax in endometrium and hysteromyoma

Yan Ding

Open publisher page 0 citations

Abstract

Objective To study the effects of mifepristone on endometrium after treatment of hysteromyoma with mifepristone.Methods The expressions of ER,PR,bcl-2,and bax in both endometrium and hysteromyoma in control group(n=20),and treatment group(n=30)were detected by immunohistochemical S-P method.Results After mifepristone treatment of hysteromyoma,the positive rates of PR expressions in hysteromyoma and endometrium in treatment group decreased(P0.05),whereas the positive rates of ER expressions in hysteromyoma and endometrium in treatment group were not different from those in control group(P0.05).The positive rate of bcl-2 expression in edometrium in mifepristone group was fower than in control group with statistically significant difference.Whereas there was no significant difference in hysteromyoma between the two groups before and after mifepristone treatment.Compared with control group,the positive rate of bax expression in hysteromyoma increased in mifepristone group(P0.05),but it did not differ in endometrium between the two groups(P0.05).83.3%(25/30)of patients in mifepristone group showed changes of proliferative phase in the endomefrium;among them,32%(8/25)showed simple hyperplasia.Conclusions Mifepristone promotes apoptosis of hysteromyoma cells,and probably contributes to proliferation of endometrium.

About this research paper

What this paper is about

Objective To study the effects of mifepristone on endometrium after treatment of hysteromyoma with mifepristone.Methods The expressions of ER,PR,bcl-2,and bax in both endometrium and hysteromyoma in control group(n=20),and treatment group(n=30)were detected by immunohistochemical S-P method.Results After mifepristone treatment of hysteromyoma,the positive rates of PR expressions in hysteromyoma and endometrium in treatment group decreased(P0.05),whereas the positive rates of ER expressions in hysteromyoma and endometrium in treatment group were not different from those in control group(P0.05).The positive rate of bcl-2 expression in edometrium in mifepristone group was fower than in control group with statistically significant difference.Whereas there was no significant difference in hysteromyoma between the two groups before and after mifepristone treatment.Compared with control group,the positive rate of bax expression in hysteromyoma increased in mifepristone group(P0.05),but it did not differ in endometrium between the two groups(P0.05).83.3%(25/30)of patients in mifepristone group showed changes of proliferative phase in the endomefrium;among them,32%(8/25)showed simple hyperplasia.Conclusions Mifepristone promotes apoptosis of hysteromyoma cells,and probably contributes to proliferation of endometrium.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the effects of mifepristone on endometrium after treatment of hysteromyoma with mifepristone.Methods The expressions of ER,PR,bcl-2,and bax in both endometrium and hysteromyoma in control group(n=20),and treatment group(n=30)were detected by immunohistochemical S-P method.Results After mifepristone treatment of hysteromyoma,the positive rates of PR expressions in hysteromyoma and endometrium in treatment group decreased(P0.05),whereas the positive rates of ER expressions in hysteromyoma and endometrium in treatment group were not different from those in control group(P0.05).The positive rate of bcl-2 expression in edometrium in mifepristone group was fower than in control group with statistically significant difference.Whereas there was no significant difference in hysteromyoma between the two groups before and after mifepristone treatment.Compared with control group,the positive rate of bax expression in hysteromyoma increased in mifepristone group(P0.05),but it did not differ in endometrium between the two groups(P0.05).83.3%(25/30)of patients in mifepristone group showed changes of proliferative phase in the endomefrium;among them,32%(8/25)showed simple hyperplasia.Conclusions Mifepristone promotes apoptosis of hysteromyoma cells,and probably contributes to proliferation of endometrium.

Key concepts: Mifepristone, Endometrium, Significant difference, Apoptosis, Immunohistochemistry, Medicine, Internal medicine, Andrology

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of mifepristone on expressions of ER,PR,bcl-2 and bax in endometrium and hysteromyoma — Research Paper | ScholarLens